|
|
|
|
MUTATION | |
-198 (T->C) Agamma; the British nd-HPFH | |
|
IDENTIFICATION | |
Cloning and DNA sequencing; restriction enzyme analysis | |
HEMATOLOGY IN HETEROZYGOTE(S) | |
Normal (Ref. 1) | Normal (Ref. 4) |
Hb F 8.5 (3.9-13.0)% (n=10) | Hb F 3.8 (1.8-5.8)% (n=12) |
Ggamma 8.0%; Agamma 92.0% (gammaCB-3) | nearly 100% Agamma (rp-HPLC) |
Hb A2 2.35 (2.0-2.7)% (n=10) | Hb A2 2.4 (1.9-2.7)% (n=5) |
| |
HEMATOLOGY IN HOMOZYGOTE(S) | |
Three adults: Hb F 19.4; 19.6; 20.4%; Ggamma 8.0%; Agamma 92.0% (gammaCB-3); Hb A2 1.7; 1.6; 1.6% |
| |
OCCURRENCE | |
In a British family and an Australian family | |
HAPLOTYPE | |
Haplotype I [+ - - - - + + +] | |
FOUND IN COMBINATION WITH ABNORMAL HB(S) | |
Not reported | |
FOUND IN COMBINATION WITH BETA-THAL ALLELE(S) | |
With beta-thal (Hb A2 5.2%; Hb F 7.9%; nearly 100% Agamma by rp-HPLC) | |
MECHANISM | |
The mutation alters the affinity of a transacting factor [see also -202 (C->G) Ggamma] | |
|
|
|
|
REFERENCES |
1. | |
Weatherall, D.J., Cartner, R., Clegg, J.B., Macrae, I.A., and Mackenzie, A.: Br. J. Haematol., 29:205, 1975. | |
2. | |
Tate, V.E., Wood, W.G., and Weatherall, D.J.: Blood, 68:1389, 1986. | |
3. | |
Donald, J.A., Lammi, A., and Trent, R.J.: Hum. Genet., 80:69, 1988. | |
4. | |
Harvey, M.P., Motum, P., Lindeman, R., and Trent, R.J.: Exp. Hematol., 20:320, 1992. | |